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Background: Electroconvulsive therapy (ECT) is commonly used to treat depression in 
older adults. Despite its efficacy in this regard, an associated increase in the risk of falls in this 
population is a downside of treatment. ECT research has focused on the incidence of falls, but 
its effect on balance and gait – intrinsic factors in instability and falls – has not been studied. Our 
aim was to examine changes in balance and gait among older adults before and after a single ECT 
session and explore the effect of patient-related and treatment factors on any changes found.
Methods: Participants were 21 older adults requiring ECT for depression in public psychi-
atric services. Patients with clinically overt mobility problems (impairing test participation or 
increasing the risk of falls) were excluded. Balance and gait testing 1 hour pre-ECT and 1, 2 
and 3 hours post-ECT included: (1) steady standing test; (2) perturbation of standing balance 
by self-initiated movements; (3) perturbation of standing balance by an external perturbation; 
and (4) timed up and go test.
Results: No deterioration in test performance was found, using one-way repeated measures 
analysis of variance.
Conclusion: Balance and gait did not deteriorate immediately after ECT. Exclusion of 
 participants with clinically overt mobility problems and falls being better attributable to  factors 
unrelated to balance and gait (such as post-ECT confusion) may account for our findings. This 
research does not repudiate the occurrence of ECT-related falls but calls into question the 
 utility of introducing routine balance and gait assessment among older ECT recipients without 
pre-existing mobility problems as a means of preventing them.
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Introduction
Electroconvulsive therapy (ECT) is one of the most effective treatments available in 
general adult and old age psychiatry. It is more effective than pharmacotherapy for 
the treatment of major depression in particular, with several studies involving older 
adults reporting high response rates of 85%.1–3 These rates are considerably higher 
than antidepressant response rates in late-life depression, which were reported in a 
recent meta-analysis to be as low as 46% in placebo-controlled trials and no more 
than 60% in comparator trials.4 ECT remains the treatment of choice for patients 
whose physical health is significantly compromised by food and fluid refusal, pro-
found psychomotor retardation, psychotic symptoms or suicidality. Older adults 
are over-represented among ECT recipients.5,6 Reasons postulated for this finding 
include a higher incidence of psychomotor retardation and psychotic features among 
depressed older adults.7
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ECT involves the induction of a therapeutic seizure under 
general anesthesia and muscle relaxation using one of three 
electrode placements. While bitemporal ECT is the most 
effective form of treatment, it is more likely to be associated 
with adverse cognitive effects (that are usually temporary). 
Right unilateral treatment results in less cognitive impairment 
but is also less effective, unless administered at adequate 
suprathreshold doses.8–11  Bifrontal placement (which avoids 
stimulation of both temporal regions) is also used in an effort 
to preserve the therapeutic advantage of bilateral treatment, 
whilst reducing the adverse cognitive effects of bitemporal 
ECT.12,13 Additional aspects of the modern ECT technique 
that aim to achieve a favorable cognitive risk-benefit profile 
include the use of a brief-pulse bidirectional waveform and 
stimulus dosing based on seizure threshold determination.
Although ECT is effective in the older population, it 
is also associated with morbidity pertaining to falls and 
confusion.14–17 Falls represent a major cause of morbidity in 
older people and are attributable to a range of host, activity 
and environmental factors.18 De Carle and Kohn19 used a 
logistic regression model, as part of a retrospective cohort 
design, to identify ECT as one of six variables associated 
with an increased risk of falling in a psychogeriatric unit. 
Draper et al20 evaluated the predictive value of a falls screen 
instrument that was administered to all patients on admission 
to an aged care psychiatry unit. The authors did not find the 
instrument to be a good predictor of falls and thus recom-
mended universal precautions for falls prevention, especially 
after ECT.20 Additional studies that examined the safety of 
ECT in older adults, and thereby the incidence of related falls, 
were based on retrospective review of medical records.1–3,14–17 
Three of these studies specifically focused on older adults 
aged 75 years and over2,3,17 and one study focused on adults 
aged 85 years and over.16 In one study, falls were documented 
in 14% of the ‘young-old’ (65–80 years) and 36% of the ‘old-
old’ (.80 years) in the period after treatment.1 Another study 
found the incidence of falls to be 15% in patients aged $60 
years compared to 0% in younger individuals.15
While research on ECT safety has focused on the 
incidence of falls, the effect of ECT on balance and gait has 
not been studied, despite balance and gait abnormalities 
being intrinsic factors contributing to instability and 
falls. It is likely that ECT impairs balance and gait in 
some vulnerable patients. Conversely, its antidepressant 
effects can lead to a rapid improvement in mood, cognition, 
confidence, mobility, nutrition and hydration, all of which 
should lead to an improvement in balance and gait over 
a treatment course.
Our main objective in undertaking this modest pilot 
study was to examine changes in balance and gait in older 
adults before and after a single ECT treatment. We sought 
to explore associations between balance and gait on the one 
hand, and patient-related factors and treatment parameters 
on the other. To the best of our knowledge, this study is the 
first to prospectively examine the effects of ECT on tests of 
 balance and gait. While the falls screening instrument devel-
oped by Draper et al20 incorporated limited testing of func-
tional mobility, it was administered routinely to all patients 
on admission to a psychogeriatric unit, rather than before 
and after an ECT treatment session. Pilot data generated by 
this project were anticipated to help build a case for a larger, 
multicenter study and eventually assist in identifying patients 
at greatest risk of falling in the context of ECT.
Materials and methods
Subjects
Participants were older adults requiring acute or mainte-
nance ECT for severe depression. Inclusion criteria were: 
(a) age $65 years; (b) informed consent to participate in the 
study; (c) unipolar or bipolar depression, either current epi-
sode or in remission; (d) ECT prescribed according to clinical 
indications and practice guidelines; (e) ambulant without 
aids; and (f) ability to communicate in English. Exclusion 
criteria were: (a) involuntary status under the Mental Health 
Act;21 and (b) clinically overt mobility problems which, in 
the opinion of a patient’s treating psychiatrist, were likely to 
impair test performance or increase the risk of falls during 
testing. (These were often due to preexisting musculoskeletal 
or neurological conditions.)
Setting
Participants were recruited from two public aged mental 
health services: Kingston Centre (MonashHealth, VIC, 
Australia) and Geelong Hospital (Barwon Health, VIC, 
Australia). At both services, ECT is administered on either 
an inpatient or outpatient basis by a multidisciplinary team of 
consultant and trainee psychiatrists and anesthetists, an ECT 
nurse coordinator and other nursing staff. The study protocol 
was approved by the Human Research Ethics Committees of 
MonashHealth and Barwon Health.
Electroconvulsive therapy procedures
ECT was administered using a Thymatron DGx or 
System IV machine (Somatics LLC, Lake Bluff, IL, 
USA). Benzodiazepine and anticonvulsant medications 
were withdrawn several days prior to ECT commencing. 
submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
806
Plakiotis et al
 
N
eu
ro
ps
yc
hi
at
ric
 D
ise
as
e 
an
d 
Tr
ea
tm
en
t d
ow
nl
oa
de
d 
fro
m
 h
ttp
s:
//w
ww
.d
ov
ep
re
ss
.c
om
/ b
y 
20
3.
10
.4
3.
23
4 
on
 2
1-
Fe
b-
20
17
Fo
r p
er
so
na
l u
se
 o
nl
y.
Powered by TCPDF (www.tcpdf.org)
                               1 / 1
Neuropsychiatric Disease and Treatment 2013:9
Preoxygenation was used prior to anesthetic induction and 
propofol and suxamethonium were the preferred anesthetic 
agents. Psychiatrists were free to choose electrode place-
ment (right unilateral, bitemporal or bifrontal), energy levels 
and treatment frequency. All psychiatrists had completed 
accredited ECT training and regularly administered ECT with 
stimulus dose titration according to statewide guidelines.22 
Information about ECT treatment parameters was collected 
from patients’ clinical records.
Clinical assessment
All participants underwent a thorough evaluation including psy-
chiatric and medical history, mental state and physical exami-
nation, medication review, blood testing, electrocardiography 
and chest X-ray. Information obtained from subjects’ clinical 
records included demographic details; falls history; and 
current psychiatric and medical medications. Mini Mental 
State Examination (MMSE)23 and Hamilton Depression 
Rating Scale (HAMD)24 scores were routinely available. 
The Barthel Index,25 a measure of physical dependence, was 
completed in consultation with nursing staff.
Balance and gait assessment
Four tests of balance and gait were administered for each 
patient, before and after a single ECT treatment, at the fol-
lowing time points: (a) 1 hour pre-ECT (T1); (b) 1 hour 
post-ECT (T2); (c) 2 hours post-ECT (T3); and (d) 3 hours 
post-ECT (T4). Testing was simple and brief, taking about 
5 minutes in total. Inter-rater reliability was checked using 
clinical staff. These tests are used routinely in the Movement 
Disorders Clinic at Kingston Centre and are safely performed 
in patients with severe physical disability.26
Steady standing test
This task measures a patient’s ability to control the body 
during upright stance without hand support. Stance positions 
included: (a) feet 10 cm apart; (b) feet together; (c) stride 
stance, with feet placed 10 cm apart and with the heel of the 
front foot in line with the toes of the rear foot; (d) tandem 
stance, with one foot directly in front of and contacting the 
other; and (e) single leg stance, with the nonweight bearing 
leg held at 45° knee flexion and the hip in neutral flexion and 
5° abduction. Footprint templates were used to guide patients. 
Stride stance and tandem stance were tested with the right 
and then the left foot forward. Single limb stance duration 
was also recorded for both feet. Each test concluded if the 
position was maintained for 30 seconds or if subjects changed 
stance position or required external support.26,27
Perturbation of standing balance  
by self-initiated movements
These tests are well-suited to assessing postural control during 
functional activity. They measure the ability of the postural 
control system to activate anticipatory responses to withstand 
potentially destabilizing perturbations produced by displace-
ment of the patient’s own body. Thus slowness in repeatedly 
raising the arm or making stepping movements may be due to 
delays in the anticipatory postural activity required to stabilize 
upright stance during these dynamic activities.27–29
Arm Raise Test: Subjects stood with their feet 10 cm 
apart on foot templates and were instructed to “Lift your 
arm up and down to shoulder height as many times as you 
can in 15 seconds when I say go.” The tester passively dem-
onstrated 90° flexion of the subject’s arm. Both arms were 
tested. The number of repetitions completed in 15 seconds 
was recorded.26,27
Step Test: Subjects stood with their feet 10 cm apart on 
foot templates, with a 15 cm high step positioned 5 cm in front 
of their toes, and were instructed as follows: “When I say go, 
step as many times as you can until I say stop. Make sure that 
the whole of your foot contacts the step each time.” Both feet 
were tested. The number of times the foot was placed fully 
onto the step in 15 seconds was recorded.26,30
Perturbation of standing balance by an external 
perturbation (shoulder tug test)
This test measures a patient’s ability to control upright 
stance in response to an external perturbation to the center 
of mass.27,31 Subjects were positioned with their feet 10 cm 
apart. The examiner stood directly behind the subject, stating: 
“I am going to tap you and I won’t let you fall.” The direc-
tion and timing of the perturbation were not mentioned. The 
shoulder was then briefly tugged in a posterior direction with 
sufficient force to destabilize the subject. Postural reactions 
were rated using the following 5-point scale: 1 = staying 
upright without taking a step; 2 = one step backwards but 
remaining steady; 3 = more than one step backwards but 
remaining steady; 4 = one or more steps backwards, followed 
by the need to be caught; and 5 = falling backwards without 
attempting to step.26,32
Timed up and go test
This test measures basic functional mobility in frail older 
adults. A chair with armrests was positioned 3 meters away 
from a marker on the floor. Subjects were seated with their 
backs against the chair and their arms on the armrests. They 
wore their usual footwear and were not physically assisted. 
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Subjects were then instructed to stand on the command “go”, 
walk to the floor marker at a comfortable and safe pace, turn 
around, return to the chair, and sit down again. Following a 
trial run, the time taken was recorded.33
Study design and statistical analyses
A prospective, repeated measures study design was used to 
assess changes in balance and gait before and after a single 
ECT treatment. One-way repeated measures analysis of vari-
ance (ANOVA) was undertaken using IBM SPSS Statistics 20 
(IBM Corporation, Somers, NY, USA). The observed power 
of each ANOVA, as calculated using SPSS, is reported in our 
results tables. To guide researchers regarding the number 
of participants that would be required for a more definitive 
future study (with 80% power, an alpha level of 5% and a 
medium effect size of 0.25),34 we also performed a priori 
power analysis (sample size calculation) based on our pilot 
data using G*Power 3.1.5 software.35,36
Results
Tables 1 and 2 summarize clinicodemographic character-
istics of study participants and ECT treatment parameters 
 respectively. Twice as many women (14) participated com-
pared to men (7). Only one (male) participant had bipolar 
depression. On average, patients had been depressed for 
7.2 months and were prescribed psychiatric medications 
from two different classes. Furthermore, they had 2.1 
comorbid medical conditions and took 3.6 nonpsychiat-
ric medications on average. Only one patient had a past 
history of falls, with the last fall occurring six months 
previously. Mean Barthel Index and MMSE scores (and 
associated standard deviations, SD) prior to treatment were 
96 (SD = 9.7) and 26 (SD = 4.0) respectively, indicating 
good performance of activities of daily living (including 
mobility) and cognitive functioning. The mean HAMD 
score was 17 (SD = 9.8) among patients receiving acute 
ECT and 6 (SD = 5.9) among patients receiving mainte-
nance treatment.
Results of balance and gait testing (including means 
and SDs for each measure across all time points), one-
way repeated measures ANOVAs and power analyses are 
presented in Tables 3 to 6. Among all these tests, the only 
item for which a statistically significant effect for time 
was found was the left arm raise test, undertaken as part 
of perturbation of standing balance by self-initiated move-
ment (Wilks’ Lambda = 0.64, F (3, 18) = 3.42, P , 0.05, 
multivariate partial eta squared = 0.36). However the 
observed increase in mean number of repetitions from 
7.81 at T2 to 8.81 at T4 was in the opposite direction to 
what might be expected if ECT was having a detrimental 
effect on balance.
Discussion
While this pilot study is novel in its aim of testing patients 
for ECT-related balance and gait abnormalities, it has several 
limitations. We could only recruit 21 patients, resulting in 
suboptimal observed power for uncovering positive asso-
ciations, ranging from 6.5% to 52.8% for different tests 
with nonsignificant findings. Achieving even this modest 
number proved exceptionally difficult, with many older 
Table 1 Patient demographic and clinical characteristics
Age
 Years (M, SD) 75.6 (5.7)
 Number aged 65–74 years 7
 Number aged 75+ years 14
Medical conditions (number of patients)
 Cardiovascular 18
 Respiratory 3
 Neurological 4
 Musculoskeletal 8
 Metabolic/endocrine 7
 Hematological 2
 Urinary 2
Non-psychiatric medications (number of patients)
 Antihypertensive 16
 Hypoglycemic 1
 Antiarrhythmic 3
 Other 19
Psychiatric medications (number of patients)
 Antidepressant 18
 Mood stabilizer 1
 Antipsychotic 11
 Benzodiazepine 3
 Hypnotic 8
Abbreviations: M, mean; SD, standard deviation.
Table 2 ECT treatment parameters
ECT type (no of patients)
 Acute 14
 Maintenance 7
Electrode placement (no of patients)
 Right unilateral 11
 Bitemporal 5
 Bifrontal 5
ECT treatment dose
 Mean Thymatron® percent energy 85.5
 Mean millicoulombs 430.9
EEG seizure duration
 Mean seconds 42.4
Average seizure energy index
 Mean value 4403.1
Postictal suppression index
 Mean percentage 51.3
Abbreviation: ECT, electroconvulsive therapy.
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Table 3 Steady standing test: results of testing, one-way repeated measures ANOVAs and power analyses
Test item Test results (N, M, SD) ANOVA results Power analyses*
Feet 10 cm apart T1 (21, 30.00, 0) No change over time
T2 (21, 30.00, 0)
T3 (21, 30.00, 0)
T4 (21, 30.00, 0)
Feet together T1 (21, 30.00, 0) No change over time
T2 (21, 30.00, 0)
T3 (21, 30.00, 0)
T4 (21, 30.00, 0)
Stride stance – 
left foot forward
T1 (21, 29.86, 0.66) No significant effect for time 22.7%, 305
T2 (21, 29.50, 2.29) Wilks’ λ = 0.86, F (3, 18) = 1.0, P = 0.415 
Multivariate partial eta squared = 0.14T3 (21, 28.90, 5.02)
T4 (21, 30.00, 0)
Stride stance – 
right foot forward
T1 (21, 28.52, 4.81) No significant effect for time 28.2%, 378
T2 (21, 29.95, 0.22) Wilks’ λ = 0.86, F (2, 19) = 1.52, P = 0.245 
Multivariate partial eta squared = 0.14T3 (21, 30.00, 0)
T4 (21, 30.00, 0)
Tandem stance – 
left foot forward
T1 (21, 15.37, 13.28) No significant effect for time 11.0%, 176
T2 (21, 14.65, 12.90) Wilks’ λ = 0.94, F (3, 18) = 0.38, P = 0.771 
Multivariate partial eta squared = 0.06T3 (21, 16.71, 13.09)
T4 (21, 14.69, 13.46)
Tandem stance – 
right foot forward
T1 (21, 19.81, 12.42) No significant effect for time 24.7%, 187
T2 (21, 17.65, 11.70) Wilks’ λ = 0.85, F (3, 18) = 1.10, P = 0.376 
Multivariate partial eta squared = 0.16T3 (21, 15.67, 11.74)
T4 (21, 14.26, 12.09)
Single leg stance – 
left leg
T1 (20, 6.93, 7.59) No significant effect for time 23.4%, 271
T2 (20, 7.34, 9.01) Wilks’ λ = 0.84, F (3, 17) = 1.05, P = 0.397 
Multivariate partial eta squared = 0.16T3 (20, 7.83, 9.57)
T4 (20, 6.05, 7.78)
Single leg stance – 
right leg
T1 (20, 7.11, 6.83) No significant effect for time 10.2%, 176
T2 (20, 7.97, 10.85) Wilks’ λ = 0.94, F (3, 17) = 0.34, P = 0.799 
Multivariate partial eta squared = 0.06T3 (20, 8.71, 10.25)
T4 (20, 9.08, 10.39)
Notes: *The first value shows the observed power of this pilot study. The second value shows the sample size required for a future prospective study to detect a medium 
effect size (f(V) = 0.25), with 80% power and an alpha level of 5%, based on 1 group with 4 measurements (1 pre, 3 post), using the non-sphericity correction from the pilot 
study for that outcome.
Abbreviations: ANOVA, analysis of variance; ECT, electroconvulsive therapy; N, number of participants; M, mean rating; SD, standard deviation; T1, 1 hour pre-ECT; T2, 1 
hour post-ECT; T3, 2 hours post-ECT; T4, 3 hours post-ECT.
ECT recipients being either incapable of consenting to 
study participation or lacking the energy and motivation to 
complete even brief bedside tests due to depression severity. 
For ethical reasons, our study excluded the very patients that 
may be at most risk of falling following ECT – those with 
 clinically overt mobility problems that impaired their ability 
to undergo testing or unduly increased the risk of test-related 
falls. Despite these recruitment problems, 14 of our patients 
were aged 75 years and over and were thus comparable in 
age to patients included in prior studies of ECT safety in the 
very old.2,3,17 In keeping with a higher prevalence of depres-
sion among women, there was a preponderance of women 
among study participants. While we examined balance and 
gait before and after ECT in a structured way, and gathered 
information regarding past falls history, we did not collect 
data on whether patients went on to have falls after ECT. 
Furthermore, although cognitive side effects of ECT are more 
likely in older individuals, our only measure of cognition was 
a pretreatment MMSE score.
Additional limitations stem from differences in the  timing 
of testing and electrode placement. Participants were tested 
at different times in the course of either acute or maintenance 
ECT. This might be important if ECT has diminishing or 
cumulative effects on balance and gait over time. The severity 
of depressive symptoms varied widely in range, in part due 
to differences in the timing of testing. Also, three different 
electrode placements were used. In all, our small patient 
numbers and negative results precluded further meaning-
ful examination of whether these factors influenced test 
performance.
Methodological factors regarding test selection and 
implementation may have also influenced results. To make 
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Table 4 Perturbation of standing balance by self-initiated movement: results of testing, one-way repeated measures ANOVAs and 
power analyses
Test item Test results (N, M, SD) ANOVA results Power analyses*
Arm raise test – 
left arm
T1 (21, 7.81, 2.50) Significant effect for time 67.0%, 248
T2 (21, 7.81, 2.68) Wilks’ λ = 0.64, F (3, 18) = 3.42, P , 0.05 
Multivariate partial eta squared = 0.36T3 (21, 8.29, 2.22)
T4 (21, 8.81, 2.50)
Arm raise test – 
right arm
T1 (21, 8.33, 2.52) No significant effect for time 52.8%, 240
T2 (21, 8.67, 2.92) Wilks’ λ = 0.70, F (3, 18) = 2.54, P = 0.089 
Multivariate partial eta squared = 0.30T3 (21, 8.76, 2.28)
T4 (21, 9.43, 2.38)
Step test – 
left foot
T1 (20, 7.40, 2.33) No significant effect for time 6.5%, 186
T2 (20, 7.30, 2.74) Wilks’ λ = 0.98, F (3, 17) = 0.10, P = 0.957 
Multivariate partial eta squared = 0.02T3 (20, 7.35, 2.28)
T4 (20, 7.50, 1.99)
Step test – 
right foot
T1 (20, 7.65, 2.18) No significant effect for time 12.5%, 176
T2 (20, 7.35, 2.96) Wilks’ λ = 0.92, F (3, 17) = 0.47, P = 0.710 
Multivariate partial eta squared = 0.08T3 (20, 7.70, 2.54)
T4 (20, 7.80, 2.59)
Notes: *The first value shows the observed power of this pilot study. The second value shows the sample size required for a future prospective study to detect a medium 
effect size (f(V) = 0.25), with 80% power and an alpha level of 5%, based on 1 group with 4 measurements (1 pre, 3 post), using the non-sphericity correction from the pilot 
study for that outcome.
Abbreviations: ANOVA, analysis of variance; ECT, electroconvulsive therapy; N, number of participants; M, mean rating; SD, standard deviation; T1, 1 hour pre-ECT; T2, 1 
hour post-ECT; T3, 2 hours post-ECT; T4, 3 hours post-ECT.
Table 5 Perturbation of standing balance by external perturbation: results of testing, one-way repeated measures ANOVA and power 
analyses
Test item Test results (N, M, SD) ANOVA results Power analyses*
Shoulder tug test T1 (20, 2.00, 1.59) No significant effect for time 23.6%, 178
T2 (20, 1.90, 1.41) Wilks’ λ = 0.84, F (3, 17) = 1.06, P = 0.394  
Multivariate partial eta squared = 0.16T3 (20, 2.15, 1.50)
T4 (20, 1.70, 1.26)
Notes: *The first value shows the observed power of this pilot study. The second value shows the sample size required for a future prospective study to detect a medium 
effect size (f(V) = 0.25), with 80% power and an alpha level of 5%, based on 1 group with 4 measurements (1 pre, 3 post), using the non-sphericity correction from the pilot 
study for that outcome.
Abbreviations: ANOVA, analysis of variance; ECT, electroconvulsive therapy; N, number of participants; M, mean rating; SD, standard deviation; T1, 1 hour pre-ECT; T2, 1 
hour post-ECT; T3, 2 hours post-ECT; T4, 3 hours post-ECT.
findings clinically applicable, we selected simple but reliable 
testing procedures not requiring specialized equipment. Mean 
scores on static tests (feet together, feet 10 cm apart and the 
stride stance components of the steady standing test) were 
consistently high, indicating a ceiling effect. These tests may 
have been insufficiently demanding to differentiate patients 
with and without balance problems in our sample. A possible 
learning effect was apparent on the left arm raise test, with an 
increase in the mean number of repetitions over 15 seconds 
being recorded over time. This raises the question of whether 
other test scores should have also improved with repeated 
performance and whether lack of improvement is itself clini-
cally noteworthy. Alternatively, the presence of an isolated 
positive finding among multiple negative comparisons may 
be due to a Type 1 error.
The above limitations make it difficult to draw definitive 
conclusions as to whether falls occurring in the context of ECT 
are mediated by treatment-related disturbances in balance and 
gait. It may be postulated on the basis of our findings that 
ECT does not give rise to intrinsic abnormalities in balance 
and gait – or that any problems are offset by improvements 
in mood and functional level – and that this is accurately 
reflected in our data. Supporting this notion is experience with 
ECT use in patients with Parkinson’s disease, where ECT has 
been used to temporarily attenuate core motor symptoms.37
Despite these observations, we do not wish to con-
vey the impression that falls do not occur following ECT 
in older adults. We have encountered post-ECT falls in 
our clinical practice and their occurrence is verified by 
research.1–3,14–17,19,20 One possible explanation for this dis-
crepancy is that we have focused on the wrong construct 
in trying to detect the emergence of subtle balance and gait 
and abnormalities following ECT, with other factors being 
more important in promoting falls in this setting. Gschwind 
et al38 note that almost all falls in older people occur while 
walking and that concurrent performance of a cognitive or 
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motor activity may cause gait disturbance and increase the 
risk of falls. In applying these observations to understanding 
our present findings, it is possible that falls occurring after 
ECT are unrelated to any directly deleterious effect of treat-
ment upon balance and gait. Rather, ECT-related cognitive 
impairment may be a mediator of falls,9,10 in keeping with 
our clinical observation that some patients who fall in this 
context are experiencing post-ECT confusion. The severity 
of a patient’s primary psychiatric condition may play a similar 
intermediary role. For example, marked apathy or psychosis 
related to depression may increase the risk of falls through 
carelessness or inattention, impaired judgment or decreased 
concern about personal safety.
Indeed, there is emerging evidence from the general falls 
prevention literature to support this postulated link between 
cognitive impairment and post-ECT falls. In a randomized 
controlled trial of patient education for falls prevention among 
medical and surgical inpatients, positive outcomes were 
achieved in patients with intact (but not impaired) cognitive 
function.39 More recently, Mirelman et al40 demonstrated that 
the risk of future falls among community living older adults 
could be predicted by performance on executive and attention 
testing 5 years earlier. From an ECT practice perspective, 
these findings emphasize the importance of using modern, 
evidence-based techniques (incorporating dose titration and 
seizure threshold determination as a basis for individualized, 
suprathreshold stimulus dosing) to maximize therapeutic 
efficacy whilst minimizing cognitive sequelae.11
For any ECT falls risk assessment to be clinically relevant, 
it should be easy to routinely implement and immediately inter-
pret on a patient-by-patient basis. Whether large scale balance 
and gait testing in ECT practice would be feasible, and then 
translate into clinically significant falls prevention outcomes, 
remains open to question. For the present screening tests to 
detect significant findings, sample sizes ranging from 176 to 
378 patients for different tests may be necessary (according 
to a priori power analysis of our pilot data). Testing so many 
patients may be impractical from both a research and clinical 
perspective. Techniques such as video gait analysis41,42 and 
computerized dynamic posturography43–45 may be more sensi-
tive than screening tests in detecting subtle gait and balance 
disturbances following ECT. It is uncertain, however, how this 
line of research would advance clinical ECT practice, as most 
ECT practitioners will not have access to sophisticated motion 
analysis systems available only in dedicated gait laboratories.
Given the recruitment difficulties encountered in the 
present prospective pilot study, a more viable approach to 
better understanding and preventing ECT-related falls in older 
adults may be to study patients who have actually fallen in 
the context of ECT. A retrospective rather than experimental 
study design may be more suitable (ethically and practically) 
for examining such high risk patients. Given the potential 
contribution of cognitive side effects and psychiatric symp-
tomatology to ECT-related falls, we recommend their routine 
evaluation using structured instruments at regular intervals 
during treatment. Systematic availability of this information 
is invaluable for auditing, quality assurance and research 
applications aimed at better identifying risk factors for falls 
and developing rational clinical guidelines for falls preven-
tion in ECT practice.
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